28 Apr 2021 14:22
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | WILLIS TOWERS WATSON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 27 April 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
1,745,577 | 1.35% | 166,654 | 0.13% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
72,359 | 0.06% | 7,134 | 0.01% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
|
|
|
| ||
TOTAL: |
|
|
|
| |
1,824,036 | 1.41% | 179,888 | 0.14% |
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 35 | 234.6100 USD |
Purchase | 50 | 236.1800 USD |
Purchase | 50 | 235.8400 USD |
Purchase | 59 | 236.2213 USD |
Purchase | 91 | 236.3400 USD |
Purchase | 100 | 235.9950 USD |
Purchase | 100 | 237.2800 USD |
Purchase | 100 | 236.8800 USD |
Purchase | 101 | 235.0426 USD |
Purchase | 134 | 236.2700 USD |
Purchase | 139 | 236.3941 USD |
Purchase | 139 | 236.0913 USD |
Purchase | 146 | 235.3932 USD |
Purchase | 191 | 230.8100 USD |
Purchase | 198 | 235.2449 USD |
Purchase | 200 | 236.3900 USD |
Purchase | 326 | 235.1633 USD |
Purchase | 715 | 236.6269 USD |
Purchase | 900 | 234.8828 USD |
Purchase | 900 | 236.4677 USD |
Purchase | 1,043 | 236.2474 USD |
Purchase | 1,680 | 236.4805 USD |
Purchase | 1,687 | 235.5458 USD |
Purchase | 2,254 | 236.5401 USD |
Purchase | 2,512 | 235.2674 USD |
Purchase | 2,869 | 235.0323 USD |
Purchase | 2,887 | 235.9554 USD |
Purchase | 3,883 | 236.3001 USD |
Purchase | 4,125 | 235.1771 USD |
Purchase | 4,932 | 236.2146 USD |
Purchase | 4,994 | 235.8600 USD |
Purchase | 5,730 | 236.2500 USD |
Purchase | 5,852 | 235.1319 USD |
Purchase | 7,049 | 234.9743 USD |
Purchase | 16,749 | 235.5709 USD |
Purchase | 21,282 | 236.2598 USD |
Sale | 8 | 236.3400 USD |
Sale | 9 | 236.3900 USD |
Sale | 24 | 236.1400 USD |
Sale | 36 | 236.4475 USD |
Sale | 45 | 236.5480 USD |
Sale | 45 | 236.5380 USD |
Sale | 46 | 236.2371 USD |
Sale | 63 | 236.5607 USD |
Sale | 81 | 236.6633 USD |
Sale | 90 | 236.5235 USD |
Sale | 99 | 236.4177 USD |
Sale | 117 | 236.4715 USD |
Sale | 126 | 236.3707 USD |
Sale | 191 | 230.8100 USD |
Sale | 192 | 236.4300 USD |
Sale | 200 | 235.6612 USD |
Sale | 200 | 236.7150 USD |
Sale | 400 | 233.3925 USD |
Sale | 738 | 236.6312 USD |
Sale | 840 | 236.4805 USD |
Sale | 992 | 236.4808 USD |
Sale | 1,612 | 235.6866 USD |
Sale | 1,823 | 236.3537 USD |
Sale | 1,833 | 235.5337 USD |
Sale | 2,337 | 236.5401 USD |
Sale | 2,977 | 235.2035 USD |
Sale | 4,218 | 235.7440 USD |
Sale | 4,926 | 235.1994 USD |
Sale | 8,499 | 236.2461 USD |
Sale | 9,601 | 236.2500 USD |
Sale | 12,055 | 235.7193 USD |
Sale | 17,829 | 236.2103 USD |
Sale | 20,000 | 235.1019 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | YES |
Date of disclosure: | 28 Apr 2021 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection |
|
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or | Number of | Exercise | Type | Expiry |
purchased | relevant securities | price |
| date | |
| to which the option |
|
|
| |
| or derivative |
|
|
| |
| relates |
|
|
| |
Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210428005662/en/
Copyright Business Wire 2021